Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...

Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify Vitamin D levels in blood ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango ...

Cadwell Industries has made a strategic investment in the Australian company Seer Medical, which specialises in epilepsy ...

The medical devices behind endometrial ablation are reshaping menstrual health. From thermocouples to transmitting wires, how ...

Carmat has secured conditional approval from the FDA to commence the second cohort of its EFS in the US with the Aeson artificial heart.

NEC Laboratories Europe and Data-Driven.AI are collaborating to advance medical diagnoses with the use of artificial intelligence (AI) and machine learning (ML).

Satio and Nanowear have entered into a partnership agreement aimed at progressing home-based diagnostic and therapeutic care.

Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD).

The FDA has approved the sale of Bruno Vision Care’s Deseyne contact lenses, which incorporate FusionTechnology, in the US market.

Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...